Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Rimsza

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Journal of Hematopathology|October 20, 2018
Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II AntigensLucas Redd, Monika Schmelz, W Richard Burack, et al.
The American Journal of Surgical Pathology|March 15, 2014
Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative studyJames R Cook, Bryan Goldman, Raymond R Tubbs, et al.
Current Oncology Reports|December 6, 2024
Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being UndetectableJulio Cartagena, Anagha Deshpande, Allison Rosenthal, et al.
Biopreservation and Biobanking|September 30, 2021
Assessment of 2-Year Storage Conditions on Protein, RNA, and DNA in Unstained Human Tissue Sections, Including a Novel Multiplex Digital Gene Expression Profiling Method with Implications for BiobankingColleen Ramsower, Lee Wisner, Katie Zellner, et al.
JAMA Oncology|February 26, 2026
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 TrialMazyar Shadman, Michael LeBlanc, Lisa Rimsza, et al.
Blood|February 10, 2011
Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytesZhi-Jian Liu, Joseph Italiano, Francisca Ferrer-Marin, et al.
The New England Journal of Medicine|February 11, 2005
Efficacy of lenalidomide in myelodysplastic syndromesAlan List, Sandy Kurtin, Denise J Roe, et al.
Biochemical Pharmacology|February 5, 2011
Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphomaWenqing Qi, Laurence S Cooke, Xiaobing Liu, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2017
The clinicopathologic spectrum of mature aggressive B cell lymphomasLisa Rimsza, Stefania Pittaluga, Stephan Dirnhofer, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2017
B-cell lymphomas with discordance between pathological features and clinical behaviorLaurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Journal of Hematopathology|October 20, 2018
Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II AntigensLucas Redd, Monika Schmelz, W Richard Burack, et al.
The American Journal of Surgical Pathology|March 15, 2014
Clinical significance of MYC expression and/or "high-grade" morphology in non-Burkitt, diffuse aggressive B-cell lymphomas: a SWOG S9704 correlative studyJames R Cook, Bryan Goldman, Raymond R Tubbs, et al.
Current Oncology Reports|December 6, 2024
Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being UndetectableJulio Cartagena, Anagha Deshpande, Allison Rosenthal, et al.
Biopreservation and Biobanking|September 30, 2021
Assessment of 2-Year Storage Conditions on Protein, RNA, and DNA in Unstained Human Tissue Sections, Including a Novel Multiplex Digital Gene Expression Profiling Method with Implications for BiobankingColleen Ramsower, Lee Wisner, Katie Zellner, et al.
JAMA Oncology|February 26, 2026
Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 TrialMazyar Shadman, Michael LeBlanc, Lisa Rimsza, et al.
Blood|February 10, 2011
Developmental differences in megakaryocytopoiesis are associated with up-regulated TPO signaling through mTOR and elevated GATA-1 levels in neonatal megakaryocytesZhi-Jian Liu, Joseph Italiano, Francisca Ferrer-Marin, et al.
The New England Journal of Medicine|February 11, 2005
Efficacy of lenalidomide in myelodysplastic syndromesAlan List, Sandy Kurtin, Denise J Roe, et al.
Biochemical Pharmacology|February 5, 2011
Aurora inhibitor MLN8237 in combination with docetaxel enhances apoptosis and anti-tumor activity in mantle cell lymphomaWenqing Qi, Laurence S Cooke, Xiaobing Liu, et al.
Virchows Archiv : an International Journal of Pathology|August 28, 2017
The clinicopathologic spectrum of mature aggressive B cell lymphomasLisa Rimsza, Stefania Pittaluga, Stephan Dirnhofer, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2017
B-cell lymphomas with discordance between pathological features and clinical behaviorLaurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, et al.
Pageof 6